TPU PHARMA
DEAD

Serial Number

86034320

Owner

Teikoku Pharma USA, Inc.

Attorney

Bret E. Field

Filing Date

Aug 9, 2013

Add to watchlist:

No watchlists yet
View on USPTO

TPU PHARMA Trademark

Serial Number: 86034320

TPU PHARMA is a trademark filed by Teikoku Pharma USA, Inc. on August 9, 2013. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Teikoku Pharma USA, Inc. (38 trademarks)

1718 Rigwood Avenue
San Jose, CA 95131

Entity Type: 03

Trademark Details

Filing Date

August 9, 2013

Registration Date

Not Registered

Published for Opposition

January 7, 2014

Goods & Services

Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics

Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; soaps for personal use; perfumery; essential oils; hair lotions

Pharmaceutical research and development; pharmaceutical product evaluation, testing and inspection services; providing medical and scientific research information in the field of pharmaceuticals; information, advisory and consultancy services relating to all the aforesaid services

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 10, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 10, 2017 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 9, 2017 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 8, 2016 EXRA
SOU EXTENSION 5 GRANTED
Sep 7, 2016 EX5G
SOU EXTENSION 5 FILED
Sep 2, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 2, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2016 EXRA
SOU EXTENSION 4 GRANTED
Mar 7, 2016 EX4G
SOU EXTENSION 4 FILED
Feb 29, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 29, 2016 EEXT
SOU TEAS EXTENSION RECEIVED
Feb 29, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2015 EXRA
SOU EXTENSION 3 GRANTED
Aug 19, 2015 EX3G
SOU EXTENSION 3 FILED
Aug 13, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 13, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2015 EXRA
SOU EXTENSION 2 GRANTED
Apr 9, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 2, 2015 AITU
SOU EXTENSION 2 FILED
Feb 26, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 26, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2014 EXRA
SOU EXTENSION 1 GRANTED
Aug 14, 2014 EX1G
SOU EXTENSION 1 FILED
Aug 14, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 14, 2014 EEXT
ASSIGNED TO EXAMINER
Jul 8, 2014 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 3, 2013 PREV
ASSIGNED TO LIE
Nov 26, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 25, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2013 CNEA
ASSIGNED TO EXAMINER
Nov 23, 2013 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Aug 21, 2013 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2013 NWOS
NEW APPLICATION ENTERED
Aug 13, 2013 NWAP